The aim of this study was to assess IGFBPs in both the serum and liver of mice during the progression of NAFLD and the onset of fibrosis in this disease, and we hypothesized that IGFBPs, through their IGF-independent actions, might have an actual role in the development of the disease. Here, IGF1 is linked to metabolic dysfunction-associated steatotic liver disease.